Non Invasive Prenatal Testing Market Size, Share & Trends Report

Non Invasive Prenatal Testing Market Size, Share & Trends Analysis Report By Gestation Period, By Pregnancy Risk, By Method, By Technology, By Product, By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030

  • Report ID: GVR-1-68038-310-2
  • Number of Report Pages: 100
  • Format: PDF, Horizon Databook
  • Historical Range: 2018 - 2022
  • Forecast Period: 2024 - 2030 
  • Industry: Healthcare

Market Segmentation

  • Non Invasive Prenatal Testing Gestation Period Outlook (Revenue, USD Million; 2018 - 2030)
    • 0-12 Weeks
    • 13-24 Weeks
    • 25-36 Weeks
  • Non Invasive Prenatal Testing Pregnancy Risk Outlook (Revenue, USD Million, 2018 - 2030)
    • High & Average Risk
    • Low Risk
  • Non Invasive Prenatal Testing Method Outlook (Revenue, USD Million, 2018 - 2030)
    • Ultrasound Detection
    • Biochemical Screening Tests
    • Cell-Free DNA in Maternal Plasma Tests
  • Non Invasive Prenatal Testing Technology Outlook (Revenue, USD Million, 2018 - 2030)
    • NGS
    • Array Technology
    • PCR
    • Others
  • Non Invasive Prenatal Testing Product Outlook (Revenue, USD Million, 2018 - 2030)
    • Consumables & Reagents
    • Instruments
  • Non Invasive Prenatal Testing Application Outlook (Revenue, USD Million, 2018 - 2030)
    • Trisomy
    • Microdeletion Syndrome
    • Other Applications
  • Non Invasive Prenatal Testing End-use Outlook (Revenue, USD Million, 2018 - 2030)
    • Hospitals & Clinics
    • Diagnostic Laboratories
  • Non Invasive Prenatal Testing Regional Outlook (Revenue, USD Million, 2018 - 2030)
    • North America
      • North America Non Invasive Prenatal Testing Market, By Gestation Period
        • 0-12 weeks
        • 13-24 weeks
        • 25-36 weeks
      • North America Non Invasive Prenatal Testing Market, By Pregnancy Risk
        • High & average risk
        • Low risk
      • North America Non Invasive Prenatal Testing Market, By Method
        • Ultrasound Detection
        • Biochemical Screening Tests
        • Cell-Free DNA in Maternal Plasma Tests
      • North America Non Invasive Prenatal Testing Market, By Technology
        • NGS
        • Array Technology
        • PCR
        • Others
      • North America Non Invasive Prenatal Testing Market, By Product
        • Consumables & Reagents
        • Instruments
      • North America Non Invasive Prenatal Testing Market, By Application
        • Trisomy
        • Microdeletion Syndrome
        • Other Applications
      • North America Non Invasive Prenatal Testing Market, By End-use
        • Hospitals & Clinics
        • Diagnostic Laboratories
      • U.S.
        • U.S. Non Invasive Prenatal Testing Market, By Gestation Period
          • 0-12 weeks
          • 13-24 weeks
          • 25-36 weeks
        • U.S. Non Invasive Prenatal Testing Market, By Pregnancy Risk
          • High & average risk
          • Low risk
        • U.S. Non Invasive Prenatal Testing Market, By Method
          • Ultrasound Detection
          • Biochemical Screening Tests
          • Cell-Free DNA in Maternal Plasma Tests
        • U.S. Non Invasive Prenatal Testing Market, By Technology
          • NGS
          • Array Technology
          • PCR
          • Others
        • U.S. Non Invasive Prenatal Testing Market, By Product
          • Consumables & Reagents
          • Instruments
        • U.S. Non Invasive Prenatal Testing Market, By Application
          • Trisomy
          • Microdeletion Syndrome
          • Other Applications
        • U.S. Non Invasive Prenatal Testing Market, By End-use
          • Hospitals & Clinics
          • Diagnostic Laboratories
      • Canada
        • Canada Non Invasive Prenatal Testing Market, By Gestation Period
          • 0-12 weeks
          • 13-24 weeks
          • 25-36 weeks
        • Canada Non Invasive Prenatal Testing Market, By Pregnancy Risk
          • High & average risk
          • Low risk
        • Canada Non Invasive Prenatal Testing Market, By Method
          • Ultrasound Detection
          • Biochemical Screening Tests
          • Cell-Free DNA in Maternal Plasma Tests
        • Canada Non Invasive Prenatal Testing Market, By Technology
          • NGS
          • Array Technology
          • PCR
          • Others
        • Canada Non Invasive Prenatal Testing Market, By Product
          • Consumables & Reagents
          • Instruments
        • Canada Non Invasive Prenatal Testing Market, By Application
          • Trisomy
          • Microdeletion Syndrome
          • Other Applications
        • Canada Non Invasive Prenatal Testing Market, By End-use
          • Hospitals & Clinics
          • Diagnostic Laboratories
    • Europe
      • Europe Non Invasive Prenatal Testing Market, By Gestation Period
        • 0-12 weeks
        • 13-24 weeks
        • 25-36 weeks
      • Europe Non Invasive Prenatal Testing Market, By Pregnancy Risk
        • High & average risk
        • Low risk
      • Europe Non Invasive Prenatal Testing Market, By Method
        • Ultrasound Detection
        • Biochemical Screening Tests
        • Cell-Free DNA in Maternal Plasma Tests
      • Europe Non Invasive Prenatal Testing Market, By Technology
        • NGS
        • Array Technology
        • PCR
        • Others
      • Europe Non Invasive Prenatal Testing Market, By Product
        • Consumables & Reagents
        • Instruments
      • Europe Non Invasive Prenatal Testing Market, By Application
        • Trisomy
        • Microdeletion Syndrome
        • Other Applications
      • Europe Non Invasive Prenatal Testing Market, By End-use
        • Hospitals & Clinics
        • Diagnostic Laboratories
      • U.K.
        • U.K. Non Invasive Prenatal Testing Market, By Gestation Period
          • 0-12 weeks
          • 13-24 weeks
          • 25-36 weeks
        • U.K. Non Invasive Prenatal Testing Market, By Pregnancy Risk
          • High & average risk
          • Low risk
        • U.K. Non Invasive Prenatal Testing Market, By Method
          • Ultrasound Detection
          • Biochemical Screening Tests
          • Cell-Free DNA in Maternal Plasma Tests
        • U.K. Non Invasive Prenatal Testing Market, By Technology
          • NGS
          • Array Technology
          • PCR
          • Others
        • U.K. Non Invasive Prenatal Testing Market, By Product
          • Consumables & Reagents
          • Instruments
        • U.K. Non Invasive Prenatal Testing Market, By Application
          • Trisomy
          • Microdeletion Syndrome
          • Other Applications
        • U.K. Non Invasive Prenatal Testing Market, By End-use
          • Hospitals & Clinics
          • Diagnostic Laboratories
      • Germany
        • Germany Non Invasive Prenatal Testing Market, By Gestation Period
          • 0-12 weeks
          • 13-24 weeks
          • 25-36 weeks
        • Germany Non Invasive Prenatal Testing Market, By Pregnancy Risk
          • High & average risk
          • Low risk
        • Germany Non Invasive Prenatal Testing Market, By Method
          • Ultrasound Detection
          • Biochemical Screening Tests
          • Cell-Free DNA in Maternal Plasma Tests
        • Germany Non Invasive Prenatal Testing Market, By Technology
          • NGS
          • Array Technology
          • PCR
          • Others
        • Germany Non Invasive Prenatal Testing Market, By Product
          • Consumables & Reagents
          • Instruments
        • Germany Non Invasive Prenatal Testing Market, By Application
          • Trisomy
          • Microdeletion Syndrome
          • Other Applications
        • Germany Non Invasive Prenatal Testing Market, By End-use
          • Hospitals & Clinics
          • Diagnostic Laboratories
      • France
        • France Non Invasive Prenatal Testing Market, By Gestation Period
          • 0-12 weeks
          • 13-24 weeks
          • 25-36 weeks
        • France Non Invasive Prenatal Testing Market, By Pregnancy Risk
          • High & average risk
          • Low risk
        • France Non Invasive Prenatal Testing Market, By Method
          • Ultrasound Detection
          • Biochemical Screening Tests
          • Cell-Free DNA in Maternal Plasma Tests
        • France Non Invasive Prenatal Testing Market, By Technology
          • NGS
          • Array Technology
          • PCR
          • Others
        • France Non Invasive Prenatal Testing Market, By Product
          • Consumables & Reagents
          • Instruments
        • France Non Invasive Prenatal Testing Market, By Application
          • Trisomy
          • Microdeletion Syndrome
          • Other Applications
        • France Non Invasive Prenatal Testing Market, By End-use
          • Hospitals & Clinics
          • Diagnostic Laboratories
      • Italy
        • Italy Non Invasive Prenatal Testing Market, By Gestation Period
          • 0-12 weeks
          • 13-24 weeks
          • 25-36 weeks
        • Italy Non Invasive Prenatal Testing Market, By Pregnancy Risk
          • High & average risk
          • Low risk
        • Italy Non Invasive Prenatal Testing Market, By Method
          • Ultrasound Detection
          • Biochemical Screening Tests
          • Cell-Free DNA in Maternal Plasma Tests
        • Italy Non Invasive Prenatal Testing Market, By Technology
          • NGS
          • Array Technology
          • PCR
          • Others
        • Italy Non Invasive Prenatal Testing Market, By Product
          • Consumables & Reagents
          • Instruments
        • Italy Non Invasive Prenatal Testing Market, By Application
          • Trisomy
          • Microdeletion Syndrome
          • Other Applications
        • Italy Non Invasive Prenatal Testing Market, By End-use
          • Hospitals & Clinics
          • Diagnostic Laboratories
      • Spain
        • Spain Non Invasive Prenatal Testing Market, By Gestation Period
          • 0-12 weeks
          • 13-24 weeks
          • 25-36 weeks
        • Spain Non Invasive Prenatal Testing Market, By Pregnancy Risk
          • High & average risk
          • Low risk
        • Spain Non Invasive Prenatal Testing Market, By Method
          • Ultrasound Detection
          • Biochemical Screening Tests
          • Cell-Free DNA in Maternal Plasma Tests
        • Spain Non Invasive Prenatal Testing Market, By Technology
          • NGS
          • Array Technology
          • PCR
          • Others
        • Spain Non Invasive Prenatal Testing Market, By Product
          • Consumables & Reagents
          • Instruments
        • Spain Non Invasive Prenatal Testing Market, By Application
          • Trisomy
          • Microdeletion Syndrome
          • Other Applications
        • Spain Non Invasive Prenatal Testing Market, By End-use
          • Hospitals & Clinics
          • Diagnostic Laboratories
      • Denmark
        • Denmark Non Invasive Prenatal Testing Market, By Gestation Period
          • 0-12 weeks
          • 13-24 weeks
          • 25-36 weeks
        • Denmark Non Invasive Prenatal Testing Market, By Pregnancy Risk
          • High & average risk
          • Low risk
        • Denmark Non Invasive Prenatal Testing Market, By Method
          • Ultrasound Detection
          • Biochemical Screening Tests
          • Cell-Free DNA in Maternal Plasma Tests
        • Denmark Non Invasive Prenatal Testing Market, By Technology
          • NGS
          • Array Technology
          • PCR
          • Others
        • Denmark Non Invasive Prenatal Testing Market, By Product
          • Consumables & Reagents
          • Instruments
        • Denmark Non Invasive Prenatal Testing Market, By Application
          • Trisomy
          • Microdeletion Syndrome
          • Other Applications
        • Denmark Non Invasive Prenatal Testing Market, By End-use
          • Hospitals & Clinics
          • Diagnostic Laboratories
      • Norway
        • Norway Non Invasive Prenatal Testing Market, By Gestation Period
          • 0-12 weeks
          • 13-24 weeks
          • 25-36 weeks
        • Norway Non Invasive Prenatal Testing Market, By Pregnancy Risk
          • High & average risk
          • Low risk
        • Norway Non Invasive Prenatal Testing Market, By Method
          • Ultrasound Detection
          • Biochemical Screening Tests
          • Cell-Free DNA in Maternal Plasma Tests
        • Norway Non Invasive Prenatal Testing Market, By Technology
          • NGS
          • Array Technology
          • PCR
          • Others
        • Norway Non Invasive Prenatal Testing Market, By Product
          • Consumables & Reagents
          • Instruments
        • Norway Non Invasive Prenatal Testing Market, By Application
          • Trisomy
          • Microdeletion Syndrome
          • Other Applications
        • Norway Non Invasive Prenatal Testing Market, By End-use
          • Hospitals & Clinics
          • Diagnostic Laboratories
      • Sweden
        • Sweden Non Invasive Prenatal Testing Market, By Gestation Period
          • 0-12 weeks
          • 13-24 weeks
          • 25-36 weeks
        • Sweden Non Invasive Prenatal Testing Market, By Pregnancy Risk
          • High & average risk
          • Low risk
        • Sweden Non Invasive Prenatal Testing Market, By Method
          • Ultrasound Detection
          • Biochemical Screening Tests
          • Cell-Free DNA in Maternal Plasma Tests
        • Sweden Non Invasive Prenatal Testing Market, By Technology
          • NGS
          • Array Technology
          • PCR
          • Others
        • Sweden Non Invasive Prenatal Testing Market, By Product
          • Consumables & Reagents
          • Instruments
        • Sweden Non Invasive Prenatal Testing Market, By Application
          • Trisomy
          • Microdeletion Syndrome
          • Other Applications
        • Sweden Non Invasive Prenatal Testing Market, By End-use
          • Hospitals & Clinics
          • Diagnostic Laboratories
    • Asia Pacific
      • Asia Pacific Non Invasive Prenatal Testing Market, By Gestation Period
        • 0-12 weeks
        • 13-24 weeks
        • 25-36 weeks
      • Asia Pacific Non Invasive Prenatal Testing Market, By Pregnancy Risk
        • High & average risk
        • Low risk
      • Asia Pacific Non Invasive Prenatal Testing Market, By Method
        • Ultrasound Detection
        • Biochemical Screening Tests
        • Cell-Free DNA in Maternal Plasma Tests
      • Asia Pacific Non Invasive Prenatal Testing Market, By Technology
        • NGS
        • Array Technology
        • PCR
        • Others
      • Asia Pacific Non Invasive Prenatal Testing Market, By Product
        • Consumables & Reagents
        • Instruments
      • Asia Pacific Non Invasive Prenatal Testing Market, By Application
        • Trisomy
        • Microdeletion Syndrome
        • Other Applications
      • Asia Pacific Non Invasive Prenatal Testing Market, By End-use
        • Hospitals & Clinics
        • Diagnostic Laboratories
      • Japan
        • Japan Non Invasive Prenatal Testing Market, By Gestation Period
          • 0-12 weeks
          • 13-24 weeks
          • 25-36 weeks
        • Japan Non Invasive Prenatal Testing Market, By Pregnancy Risk
          • High & average risk
          • Low risk
        • Japan Non Invasive Prenatal Testing Market, By Method
          • Ultrasound Detection
          • Biochemical Screening Tests
          • Cell-Free DNA in Maternal Plasma Tests
        • Japan Non Invasive Prenatal Testing Market, By Technology
          • NGS
          • Array Technology
          • PCR
          • Others
        • Japan Non Invasive Prenatal Testing Market, By Product
          • Consumables & Reagents
          • Instruments
        • Japan Non Invasive Prenatal Testing Market, By Application
          • Trisomy
          • Microdeletion Syndrome
          • Other Applications
        • Japan Non Invasive Prenatal Testing Market, By End-use
          • Hospitals & Clinics
          • Diagnostic Laboratories
      • China
        • China Non Invasive Prenatal Testing Market, By Gestation Period
          • 0-12 weeks
          • 13-24 weeks
          • 25-36 weeks
        • China Non Invasive Prenatal Testing Market, By Pregnancy Risk
          • High & average risk
          • Low risk
        • China Non Invasive Prenatal Testing Market, By Method
          • Ultrasound Detection
          • Biochemical Screening Tests
          • Cell-Free DNA in Maternal Plasma Tests
        • China Non Invasive Prenatal Testing Market, By Technology
          • NGS
          • Array Technology
          • PCR
          • Others
        • China Non Invasive Prenatal Testing Market, By Product
          • Consumables & Reagents
          • Instruments
        • China Non Invasive Prenatal Testing Market, By Application
          • Trisomy
          • Microdeletion Syndrome
          • Other Applications
        • China Non Invasive Prenatal Testing Market, By End-use
          • Hospitals & Clinics
          • Diagnostic Laboratories
      • South Korea
        • South Korea Non Invasive Prenatal Testing Market, By Gestation Period
          • 0-12 weeks
          • 13-24 weeks
          • 25-36 weeks
        • South Korea Non Invasive Prenatal Testing Market, By Pregnancy Risk
          • High & average risk
          • Low risk
        • South Korea Non Invasive Prenatal Testing Market, By Method
          • Ultrasound Detection
          • Biochemical Screening Tests
          • Cell-Free DNA in Maternal Plasma Tests
        • South Korea Non Invasive Prenatal Testing Market, By Technology
          • NGS
          • Array Technology
          • PCR
          • Others
        • South Korea Non Invasive Prenatal Testing Market, By Product
          • Consumables & Reagents
          • Instruments
        • South Korea Non Invasive Prenatal Testing Market, By Application
          • Trisomy
          • Microdeletion Syndrome
          • Other Applications
        • South Korea Non Invasive Prenatal Testing Market, By End-use
          • Hospitals & Clinics
          • Diagnostic Laboratories
      • India
        • India Non Invasive Prenatal Testing Market, By Gestation Period
          • 0-12 weeks
          • 13-24 weeks
          • 25-36 weeks
        • India Non Invasive Prenatal Testing Market, By Pregnancy Risk
          • High & average risk
          • Low risk
        • India Non Invasive Prenatal Testing Market, By Method
          • Ultrasound Detection
          • Biochemical Screening Tests
          • Cell-Free DNA in Maternal Plasma Tests
        • India Non Invasive Prenatal Testing Market, By Technology
          • NGS
          • Array Technology
          • PCR
          • Others
        • India Non Invasive Prenatal Testing Market, By Product
          • Consumables & Reagents
          • Instruments
        • India Non Invasive Prenatal Testing Market, By Application
          • Trisomy
          • Microdeletion Syndrome
          • Other Applications
        • India Non Invasive Prenatal Testing Market, By End-use
          • Hospitals & Clinics
          • Diagnostic Laboratories
      • Australia
        • Australia Non Invasive Prenatal Testing Market, By Gestation Period
          • 0-12 weeks
          • 13-24 weeks
          • 25-36 weeks
        • Australia Non Invasive Prenatal Testing Market, By Pregnancy Risk
          • High & average risk
          • Low risk
        • Australia Non Invasive Prenatal Testing Market, By Method
          • Ultrasound Detection
          • Biochemical Screening Tests
          • Cell-Free DNA in Maternal Plasma Tests
        • Australia Non Invasive Prenatal Testing Market, By Technology
          • NGS
          • Array Technology
          • PCR
          • Others
        • Australia Non Invasive Prenatal Testing Market, By Product
          • Consumables & Reagents
          • Instruments
        • Australia Non Invasive Prenatal Testing Market, By Application
          • Trisomy
          • Microdeletion Syndrome
          • Other Applications
        • Australia Non Invasive Prenatal Testing Market, By End-use
          • Hospitals & Clinics
          • Diagnostic Laboratories
      • Thailand
        • Thailand Non Invasive Prenatal Testing Market, By Gestation Period
          • 0-12 weeks
          • 13-24 weeks
          • 25-36 weeks
        • Thailand Non Invasive Prenatal Testing Market, By Pregnancy Risk
          • High & average risk
          • Low risk
        • Thailand Non Invasive Prenatal Testing Market, By Method
          • Ultrasound Detection
          • Biochemical Screening Tests
          • Cell-Free DNA in Maternal Plasma Tests
        • Thailand Non Invasive Prenatal Testing Market, By Technology
          • NGS
          • Array Technology
          • PCR
          • Others
        • Thailand Non Invasive Prenatal Testing Market, By Product
          • Consumables & Reagents
          • Instruments
        • Thailand Non Invasive Prenatal Testing Market, By Application
          • Trisomy
          • Microdeletion Syndrome
          • Other Applications
        • Thailand Non Invasive Prenatal Testing Market, By End-use
          • Hospitals & Clinics
          • Diagnostic Laboratories
    • Latin America
      • Latin America Non Invasive Prenatal Testing Market, By Gestation Period
        • 0-12 weeks
        • 13-24 weeks
        • 25-36 weeks
      • Latin America Non Invasive Prenatal Testing Market, By Pregnancy Risk
        • High & average risk
        • Low risk
      • Latin America Non Invasive Prenatal Testing Market, By Method
        • Ultrasound Detection
        • Biochemical Screening Tests
        • Cell-Free DNA in Maternal Plasma Tests
      • Latin America Non Invasive Prenatal Testing Market, By Technology
        • NGS
        • Array Technology
        • PCR
        • Others
      • Latin America Non Invasive Prenatal Testing Market, By Product
        • Consumables & Reagents
        • Instruments
      • Latin America Non Invasive Prenatal Testing Market, By Application
        • Trisomy
        • Microdeletion Syndrome
        • Other Applications
      • Latin America Non Invasive Prenatal Testing Market, By End-use
        • Hospitals & Clinics
        • Diagnostic Laboratories
      • Brazil
        • Brazil Non Invasive Prenatal Testing Market, By Gestation Period
          • 0-12 weeks
          • 13-24 weeks
          • 25-36 weeks
        • Brazil Non Invasive Prenatal Testing Market, By Pregnancy Risk
          • High & average risk
          • Low risk
        • Brazil Non Invasive Prenatal Testing Market, By Method
          • Ultrasound Detection
          • Biochemical Screening Tests
          • Cell-Free DNA in Maternal Plasma Tests
        • Brazil Non Invasive Prenatal Testing Market, By Technology
          • NGS
          • Array Technology
          • PCR
          • Others
        • Brazil Non Invasive Prenatal Testing Market, By Product
          • Consumables & Reagents
          • Instruments
        • Brazil Non Invasive Prenatal Testing Market, By Application
          • Trisomy
          • Microdeletion Syndrome
          • Other Applications
        • Brazil Non Invasive Prenatal Testing Market, By End-use
          • Hospitals & Clinics
          • Diagnostic Laboratories
      • Mexico
        • Mexico Non Invasive Prenatal Testing Market, By Gestation Period
          • 0-12 weeks
          • 13-24 weeks
          • 25-36 weeks
        • Mexico Non Invasive Prenatal Testing Market, By Pregnancy Risk
          • High & average risk
          • Low risk
        • Mexico Non Invasive Prenatal Testing Market, By Method
          • Ultrasound Detection
          • Biochemical Screening Tests
          • Cell-Free DNA in Maternal Plasma Tests
        • Mexico Non Invasive Prenatal Testing Market, By Technology
          • NGS
          • Array Technology
          • PCR
          • Others
        • Mexico Non Invasive Prenatal Testing Market, By Product
          • Consumables & Reagents
          • Instruments
        • Mexico Non Invasive Prenatal Testing Market, By Application
          • Trisomy
          • Microdeletion Syndrome
          • Other Applications
        • Mexico Non Invasive Prenatal Testing Market, By End-use
          • Hospitals & Clinics
          • Diagnostic Laboratories
      • Argentina
        • Argentina Non Invasive Prenatal Testing Market, By Gestation Period
          • 0-12 weeks
          • 13-24 weeks
          • 25-36 weeks
        • Argentina Non Invasive Prenatal Testing Market, By Pregnancy Risk
          • High & average risk
          • Low risk
        • Argentina Non Invasive Prenatal Testing Market, By Method
          • Ultrasound Detection
          • Biochemical Screening Tests
          • Cell-Free DNA in Maternal Plasma Tests
        • Argentina Non Invasive Prenatal Testing Market, By Technology
          • NGS
          • Array Technology
          • PCR
          • Others
        • Argentina Non Invasive Prenatal Testing Market, By Product
          • Consumables & Reagents
          • Instruments
        • Argentina Non Invasive Prenatal Testing Market, By Application
          • Trisomy
          • Microdeletion Syndrome
          • Other Applications
        • Argentina Non Invasive Prenatal Testing Market, By End-use
          • Hospitals & Clinics
          • Diagnostic Laboratories
    • MEA
      • MEA Non Invasive Prenatal Testing Market, By Gestation Period
        • 0-12 weeks
        • 13-24 weeks
        • 25-36 weeks
      • MEA Non Invasive Prenatal Testing Market, By Pregnancy Risk
        • High & average risk
        • Low risk
      • MEA Non Invasive Prenatal Testing Market, By Method
        • Ultrasound Detection
        • Biochemical Screening Tests
        • Cell-Free DNA in Maternal Plasma Tests
      • MEA Non Invasive Prenatal Testing Market, By Technology
        • NGS
        • Array Technology
        • PCR
        • Others
      • MEA Non Invasive Prenatal Testing Market, By Product
        • Consumables & Reagents
        • Instruments
      • MEA Non Invasive Prenatal Testing Market, By Application
        • Trisomy
        • Microdeletion Syndrome
        • Other Applications
      • MEA Non Invasive Prenatal Testing Market, By End-use
        • Hospitals & Clinics
        • Diagnostic Laboratories
      • South Africa
        • South Africa Non Invasive Prenatal Testing Market, By Gestation Period
          • 0-12 weeks
          • 13-24 weeks
          • 25-36 weeks
        • South Africa Non Invasive Prenatal Testing Market, By Pregnancy Risk
          • High & average risk
          • Low risk
        • South Africa Non Invasive Prenatal Testing Market, By Method
          • Ultrasound Detection
          • Biochemical Screening Tests
          • Cell-Free DNA in Maternal Plasma Tests
        • South Africa Non Invasive Prenatal Testing Market, By Technology
          • NGS
          • Array Technology
          • PCR
          • Others
        • South Africa Non Invasive Prenatal Testing Market, By Product
          • Consumables & Reagents
          • Instruments
        • South Africa Non Invasive Prenatal Testing Market, By Application
          • Trisomy
          • Microdeletion Syndrome
          • Other Applications
        • South Africa Non Invasive Prenatal Testing Market, By End-use
          • Hospitals & Clinics
          • Diagnostic Laboratories
      • Saudi Arabia
        • Saudi Arabia Non Invasive Prenatal Testing Market, By Gestation Period
          • 0-12 weeks
          • 13-24 weeks
          • 25-36 weeks
        • Saudi Arabia Non Invasive Prenatal Testing Market, By Pregnancy Risk
          • High & average risk
          • Low risk
        • Saudi Arabia Non Invasive Prenatal Testing Market, By Method
          • Ultrasound Detection
          • Biochemical Screening Tests
          • Cell-Free DNA in Maternal Plasma Tests
        • Saudi Arabia Non Invasive Prenatal Testing Market, By Technology
          • NGS
          • Array Technology
          • PCR
          • Others
        • Saudi Arabia Non Invasive Prenatal Testing Market, By Product
          • Consumables & Reagents
          • Instruments
        • Saudi Arabia Non Invasive Prenatal Testing Market, By Application
          • Trisomy
          • Microdeletion Syndrome
          • Other Applications
        • Saudi Arabia Non Invasive Prenatal Testing Market, By End-use
          • Hospitals & Clinics
          • Diagnostic Laboratories
      • UAE
        • UAE Non Invasive Prenatal Testing Market, By Gestation Period
          • 0-12 weeks
          • 13-24 weeks
          • 25-36 weeks
        • UAE Non Invasive Prenatal Testing Market, By Pregnancy Risk
          • High & average risk
          • Low risk
        • UAE Non Invasive Prenatal Testing Market, By Method
          • Ultrasound Detection
          • Biochemical Screening Tests
          • Cell-Free DNA in Maternal Plasma Tests
        • UAE Non Invasive Prenatal Testing Market, By Technology
          • NGS
          • Array Technology
          • PCR
          • Others
        • UAE Non Invasive Prenatal Testing Market, By Product
          • Consumables & Reagents
          • Instruments
        • UAE Non Invasive Prenatal Testing Market, By Application
          • Trisomy
          • Microdeletion Syndrome
          • Other Applications
        • UAE Non Invasive Prenatal Testing Market, By End-use
          • Hospitals & Clinics
          • Diagnostic Laboratories
      • Kuwait
        • Kuwait Non Invasive Prenatal Testing Market, By Gestation Period
          • 0-12 weeks
          • 13-24 weeks
          • 25-36 weeks
        • Kuwait Non Invasive Prenatal Testing Market, By Pregnancy Risk
          • High & average risk
          • Low risk
        • Kuwait Non Invasive Prenatal Testing Market, By Method
          • Ultrasound Detection
          • Biochemical Screening Tests
          • Cell-Free DNA in Maternal Plasma Tests
        • Kuwait Non Invasive Prenatal Testing Market, By Technology
          • NGS
          • Array Technology
          • PCR
          • Others
        • Kuwait Non Invasive Prenatal Testing Market, By Product
          • Consumables & Reagents
          • Instruments
        • Kuwait Non Invasive Prenatal Testing Market, By Application
          • Trisomy
          • Microdeletion Syndrome
          • Other Applications
        • Kuwait Non Invasive Prenatal Testing Market, By End-use
          • Hospitals & Clinics
          • Diagnostic Laboratories

Non Invasive Prenatal Testing Market Dynamics

Driver: Increasing demand for early and non-invasive fetal testing procedure

The demand for NIPT is increasing in various countries, owing to factors such as an increasing number of doctors choosing advanced genetic testing for high-risk pregnancies and a desire to delay pregnancy, more pregnancy-related problems in the third- or second trimester. The use of invasive techniques of prenatal testing, such as chorionic villus sampling and amniocentesis, can lead to issues such as miscarriage. This has led to a decline in the use of these procedures and high demand for tests that are more efficient, noninvasive, & safe. NIPT, through the use of cellfree fetal DNA (cffDNA) that circulates in the mother’s blood, can be used for the detection of commonly occurring trisomies in fetus such as Turner syndrome, Down syndrome, fetal Rhesus D status, and sex chromosome disorders as well as for determination of fetal sex. Furthermore, noninvasive fetal tests have a lower failure and false-positive rate, which has resulted in considerable increase in the uptake of noninvasive tests in the last few years. Other advantages of NIPT include precise results in overweight & obese women and detection of a higher number of genetic disorders such as microdeletions.

Driver: Surge in number of collaborations and licensing agreements

The market is highly saturated with existing key players. Companies in the market are forming strategic partnerships and collaborations to maintain a stable position in the market. For instance, in January 2022, QIAGEN and Atila BioSystems collaborated to provide NIPT solutions to boost the application portfolio of its digital PCR platform QIAcuity. Moreover, in June 2021, Illumina entered into a strategic collaboration with Next Generation Genomic to introduce a CE-IVD, NGS-based NIPT test, VeriSeq NIPT Solution v2 in Thailand. With this initiative, Illumina would have greater patient access to NIPT's next-generation sequencing. By analyzing over 2,300 plasma specimens from pregnant women with twin and singleton pregnancies who underwent prenatal screening for fetal chromosome aneuploidies and partial duplications and deletions of 7 Mb or larger, the clinical accuracy of the VeriSeq NIPT Solution v2 was confirmed.

In August 2022, LGC Clinical Diagnostics extended and expanded its partnership with the Stanford University Department of Obstetrics and Gynecology for NIPT reference materials. Under the agreement, Stanford planned to keep providing LGC clinical advice on patient recruitment and selection whose pregnancy has been detected as having a genetic abnormality. Moreover, in June 2021, Roche Diagnostics Korea and Seoul Clinical Laboratories (SCL) collaborated to offer the Harmony NIPT in South Korea. The test can screen for specific chromosomal conditions in 10 weeks of gestation of pregnancy, with a low risk of complications, including preterm labor and stillbirth.

Restraint: Ethical concerns regarding reproductive genetics

NIPTs have not yet been validated as a diagnostic tool. However, they can be used for nonmedical traits, such as the sex of the fetus at an early stage of the pregnancy, that can lead to abortions based on the sex of the fetus. Ethical and legal issues relating to implementation of reproductive genetic testing are expected to hamper sector growth. Moreover, NIPT raises some new moral concerns; it also exacerbates or confirms some that have long been linked to other prenatal testing methods. The concern that NIPT may encourage sex-selective abortion by accurately disclosing fetal sex during the first trimester is one of the new ethical dilemmas it raises; the scientific possibility for employing NIPT for a broader range of ailments that have less impact on functioning; the availability of information on genetic characteristics with unclear clinical significance that may be worrying. The ethical issues that are related to NIPT include the facilitation to make informed decisions regarding the sex selection of the fetus, which is considered illegal in many nations and raises ethical concerns about gender selection. In addition, NIPT is morally unacceptable because of involvement of unnatural creation and destruction of human embryo post-sex determination in certain regions of the globe. Application of NIPT for sex selection on non-medical backgrounds is prohibited, which is expected to restrain market growth in certain countries where sex-based abortions are prevalent. Additional policy guidance is needed for clinicians to address these issues and reduce the impact of this restraint over the forecast period.

What Does This Report Include?

This section will provide insights into the contents included in this non invasive prenatal testing market report and help gain clarity on the structure of the report to assist readers in navigating smoothly.

Non invasive prenatal testing market qualitative analysis

  • Industry overview

  • Industry trends

  • Market drivers and restraints

  • Market size

  • Growth prospects

  • Porter’s analysis

  • PESTEL analysis

  • Key market opportunities prioritized

  • Competitive landscape

    • Company overview

    • Financial performance

    • Product benchmarking

    • Latest strategic developments

Non invasive prenatal testing market quantitative analysis

  • Market size, estimates, and forecast from 2018 to 2030

  • Market estimates and forecast for product segments up to 2030

  • Regional market size and forecast for product segments up to 2030

  • Market estimates and forecast for application segments up to 2030

  • Regional market size and forecast for application segments up to 2030

  • Company financial performance

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

ISO

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon